Recon: Roche to buy MASH biotech 89bio for $2.4B; Kennedy’s ACIP weighs changes to childhood vaccines

• Federal vaccine adviser says former CDC officials can’t be trusted unless they agree to ‘public debate’ (STAT)
• Key takeaways on CDC hearing: Vaccine moves, experts sidelined, GOP attacks (The Hill)
• Kennedy's hand-picked CDC panel weighs changes to children's vaccines (Reuters)
• Despite fear of retaliation, hundreds of federal workers urge Congress to protect medicine and science (STAT)
• HHS abruptly cancels CDC meeting with RFK Jr., anti-vaccine activist as scrutiny mounts (STAT)
• Kennedy is rewriting US vaccine policy — fast and on his terms (Reuters)
• New US global health plan prioritizes drugs, recipients' self-reliance (Reuters)
• US Shutdown Risks Rise as Democrats Dig In on Health-Care Fixes (Bloomberg)

• WHO says 31 of 38 Ebola cases in Congo have resulted in deaths (STAT)
• Alcohol, tobacco and food giants block health reforms, says WHO (Reuters)
• Logistics real estate company promises £3.9B in UK life sciences investment (Endpoints)
• GE Healthcare Said to Weigh Selling Stake in China Business (Bloomberg)
• J&J launches IVL device in Europe; Medtronic looks at pacing for more patients (MedTech Dive)
• Have Your Say On EU Digital Regulation Overkill (MedTech Insight)

• Roche to enter FGF21 space with $2.4B buyout of MASH biotech 89bio (Endpoints)
• Sangamo’s Fabry therapy partner search looks futile (STAT)
• Wegovy-maker Novo Nordisk starts 'fight back' as investors return (Reuters)
• Novo Jumps Most in Month as Ozempic Beats Older Lilly Drug (Bloomberg)
• Replimune's stock sinks on rocky path forward for cancer drug's accelerated approval (Endpoints)
• Nektar’s stock rallies on eczema data; Novo to lay off 263 workers in NJ (Endpoints)
• Pfizer, Arvinas sell rights to lead PROTAC one month after filing for FDA review (Endpoints)
• After trial win, Lilly's Mounjaro primed for expansion in kids 10-17 with type 2 diabetes (Fierce Pharma)

• Fresh data on hospital AI use & Califf dishes on tech (STAT)
• House committee advances Medicare coverage bill for breakthrough devices (MedTech Dive)
• Pair Of Safety Alerts In Line With Broader FDA Enforcement Crackdown (MedTech Insight)

• RFK Jr.’s Assault on Ultra-Processed Foods Puts Companies on Edge (Bloomberg)
• JM Smucker to raise coffee prices again in the face of tariffs (Food Dive)

• I’m a former CDC director. I’m deeply concerned about the future of vaccines in the U.S. (STAT)
• NIH outlines new system for awarding research grants to foreign scientists (STAT)
• Here’s who will be hit with higher premiums if ACA enhanced subsidies expire (STAT)
• The coming fragmentation of vaccination social order (STAT)
• FDA’s New Cosmetic Adverse Event Dashboard Presents Challenges and Opportunities (FDA Law Blog)
• Obamacare Subsidy Extension Would Cost $350 Billion, CBO Finds (Bloomberg)